Phage therapy gets a boost: Scientists unlock the secret to broader-acting bacteria killers

Bacteriophages — viruses that hunt and kill bacteria — have long been seen as a promising weapon against antibiotic-resistant infections. But there's a catch: most phages are highly selective, targeting only one bacterial strain. Now, researchers from McMaster University have figured out what makes some phages broader hunters, and it comes down to the shape of their tails.

Published in PNAS, the study analyzed over 1,300 strains of Pseudomonas aeruginosa — a hospital-acquired pathogen increasingly resistant to nearly all antibiotics — and identified 53 distinct variants of the bacterial fibers (pili) that phages latch onto. Broader-spectrum phages had more structural diversity at the tail fiber contact point, allowing them to tolerate variation in bacterial targets. Narrow-spectrum phages, by contrast, lost infectivity with even minor changes in pili structure.

Key Takeaways:

• Tail fiber shape may serve as a reliable predictor of a phage's host range and clinical utility
• Identifying broader-spectrum phages could significantly reduce the time needed to match a phage to a patient's specific infection
• P. aeruginosa has likely evolved diverse pili variants as a defense against local phage populations
• Phage therapy has already shown real-world success, including clearing a multi-year drug-resistant UTI in a Canadian patient

Why it matters: With antibiotic-resistant infections killing millions annually, phage therapy represents one of the most viable alternatives to conventional antibiotics. This structural insight could shift phage selection from trial-and-error to a more predictive, targeted approach — making treatment faster and more accessible for patients with few remaining options.